Cargando…

IL-18 deficiency ameliorates the progression from AKI to CKD

Inflammation is an important factor in the progression from acute kidney injury (AKI) to chronic kidney disease (CKD). The role of interleukin (IL)-18 in this progression has not been examined. We aimed to clarify whether and how IL-18 limits this progression. In a folic acid induced renal injury mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luan, Junjun, Fu, Jingqi, Jiao, Congcong, Hao, Xiangnan, Feng, Zixuan, Zhu, Lingzi, Zhang, Yixiao, Zhou, Guangyu, Li, Hongyu, Yang, Wei, Yuen, Peter S. T., Kopp, Jeffrey B., Pi, Jingbo, Zhou, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666542/ https://www.ncbi.nlm.nih.gov/pubmed/36379914 http://dx.doi.org/10.1038/s41419-022-05394-4

Ejemplares similares

LNA-anti-miR-150 alleviates renal interstitial fibrosis by reducing pro-inflammatory M1/M2 macrophage polarization
por: Hao, Xiangnan, et al.
Publicado: (2022)

circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus Nephritis
por: Luan, Junjun, et al.
Publicado: (2022)

LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration
por: Luan, Junjun, et al.
Publicado: (2019)

miR-150-Based RNA Interference Attenuates Tubulointerstitial Fibrosis through the SOCS1/JAK/STAT Pathway In Vivo and In Vitro
por: Luan, Junjun, et al.
Publicado: (2020)

circHIPK3 Exacerbates Folic Acid-Induced Renal Tubulointerstitial Fibrosis by Sponging miR-30a
por: Wu, Yan, et al.
Publicado: (2022)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

Infectious consequences of the AKI-to-CKD transition
por: Sánchez Horrillo, Ana, et al.
Publicado: (2022)

Dynamic signature of lymphangiogenesis during AKI and CKD
por: Zarjou, Abolfazl, et al.
Publicado: (2019)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Meta-analysis of AKI to CKD transition in perioperative patients
por: M. Abdala, Pedro, et al.
Publicado: (2021)

Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition
por: Tanemoto, Fumiaki, et al.
Publicado: (2022)

From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms
por: Wang, Zhiwen, et al.
Publicado: (2022)

Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation
por: Nishida, Kento, et al.
Publicado: (2021)

The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation
por: Kant, Sam, et al.
Publicado: (2020)

HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression
por: Zhang, Lijun, et al.
Publicado: (2023)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

EGFR drives the progression of AKI to CKD through HIPK2 overexpression
por: Xu, Luyang, et al.
Publicado: (2019)

The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
por: Guo, Runzhi, et al.
Publicado: (2023)

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
por: Yao, Mengying, et al.
Publicado: (2022)

The critical role of FXR is associated with the regulation of autophagy and apoptosis in the progression of AKI to CKD
por: Kim, Dong-Hyun, et al.
Publicado: (2021)

Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence
por: Chen, Jia-Huang, et al.
Publicado: (2021)

circHLA-C Plays an Important Role in Lupus Nephritis by Sponging miR-150
por: Luan, Junjun, et al.
Publicado: (2017)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease
por: Lee, Kyung, et al.
Publicado: (2022)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
por: Hu, Zhizhi, et al.
Publicado: (2023)

A potential link between fibroblast growth factor-23 and the progression of AKI to CKD
por: Lu, Yinghui, et al.
Publicado: (2023)

Altered gut microbiome plays an important role in AKI to CKD transition in aged mice
por: Kim, Myung-Gyu, et al.
Publicado: (2023)

Co-occurrence of IgA nephropathy and IgG4-Tubulointersitial nephritis effectively treated with tacrolimus: a case report
por: Tian, Mi, et al.
Publicado: (2021)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

The VEGF Inhibitor Soluble Fms-like Tyrosine Kinase 1 Does Not Promote AKI-to-CKD Transition
por: van Aanhold, Cleo C. L., et al.
Publicado: (2022)

Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection
por: Song, Jianling, et al.
Publicado: (2023)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

Microparticles and MicroRNAs of Endothelial Progenitor Cells Ameliorate AKI
por: Bitzer, Markus, et al.
Publicado: (2012)

Genetic or pharmacologic inhibition of EGFR ameliorates sepsis-induced AKI
por: Xu, Xuan, et al.
Publicado: (2017)

Ischemic Duration and Frequency Determines AKI-to-CKD Progression Monitored by Dynamic Changes of Tubular Biomarkers in IRI Mice
por: Dong, Yang, et al.
Publicado: (2019)

Tubular Cell Cycle Response upon AKI: Revising Old and New Paradigms to Identify Novel Targets for CKD Prevention
por: De Chiara, Letizia, et al.
Publicado: (2021)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

Epidemiology and outcomes of post-AKI proteinuria
por: Su, Licong, et al.
Publicado: (2023)

Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
por: Huang, Mengjie, et al.
Publicado: (2022)

Latent AKI is… still AKI: the quantification of the burden of renal dysfunction
por: Ricci, Zaccaria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_djp5rr9e6leoc0vdoupvf4hmkm